- seekingalpha.com
- Posted On 03 November 2026
ARS Pharmaceuticals: Lawsuits And Cash Burn Are Priced In, Yet The Stock Keeps Falling
ARS Pharmaceuticals, Inc. ( SPRY ) is an early commercial-stage company that has a targeted platform approach. What this means is that one delivery system (an i...
Source:
seekingalpha.com